Skip to content

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

Assessing Patient Engagement and Understanding in Chronic Fatigue Syndrome Clinical Trials

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05967494
Enrollment
500
Registered
2023-08-01
Start date
2024-08-31
Completion date
2026-08-31
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Keywords

Chronic Fatigue Syndrome

Brief summary

The study seeks to delve into the firsthand experiences of patients diagnosed with chronic fatigue syndrome who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all chronic fatigue syndrome patients as well as those in under-represented demographic groups.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Signed Written Informed Consent * Aged ≥ 18 years old * No prior treatment for chronic fatigue syndrome

Exclusion criteria

* Participant is actively receiving study therapy in another * Inability to provide written informed consent * Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Design outcomes

Primary

MeasureTime frame
Rate of patients who decide to join in a chronic fatigue syndrome clinical trial3 months
Number of chronic fatigue syndrome patients who remain in clinical trial until completion12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com(415) 900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026